Erasme University Hospital
erasme.ulb.ac.beTotal trials
177
Active
23
Phase 3
5
Total enrollment
92,066
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Sodium Lactate Solution | — | — | — | — | — | 1 | |
| mFOLFIRINOX or Gemcitabine nab-paclitaxel | — | — | — | — | — | 1 | |
| Sedation with dexmedetomidine | — | — | — | — | — | 1 | |
| sedation propofol and remifentanil | — | — | — | — | — | 1 |
Next readouts
- 2027-05-30
- 2027-12-31
- 2027-12-31
Top conditions
- Anesthesia10
- Obesity5
- Surgery5
- Alcoholic Liver Disease4
- Hemodynamic Instability4
- Healthy4
- Technology4
- Closed-Loop Communication3
Frequently asked questions about Erasme University Hospital
- How many clinical trials does Erasme University Hospital have on ClinicalTrials.gov?
- Erasme University Hospital is listed as the lead sponsor on 177 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Erasme University Hospital's trials are in Phase 3?
- 5 of Erasme University Hospital's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Erasme University Hospital focus on?
- Erasme University Hospital's most-studied conditions on ClinicalTrials.gov are Anesthesia, Obesity, Surgery, Alcoholic Liver Disease, Hemodynamic Instability.
- When are Erasme University Hospital's next clinical trial readouts?
- Erasme University Hospital has 3 upcoming primary-completion readouts tracked here; the soonest is “Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure”, expected around 2027-05-30.